Group 1 - The announcement of the effective contract for the Dongfang Hong Medical Innovation Mixed Securities Investment Fund (QDII) was made by Dongfang Securities Asset Management Co., Ltd. [1] - The total net subscription amount during the fundraising period was 1,981,142,834.72 yuan, with interest accrued during the fundraising period amounting to 184,438.96 yuan, resulting in a total subscription share of 1,981,327,273.68 shares [1] - The fund manager, Gao Yi, has a background as a senior macro strategy researcher and chief strategist at Dongfang Securities Research Institute, and currently serves as the fund manager at Shanghai Dongfang Securities Asset Management Co., Ltd. [1] Group 2 - Jiang Qi, another key figure, has held various positions including pharmaceutical industry analyst at CITIC Securities, and chief analyst at Zhongtai Securities, and is currently the head of equity research at Shanghai Dongfang Securities Asset Management Co., Ltd. [1]
东方红医疗创新混合QDII成立 规模19.8亿元